title: Letter from the editor.
authors: Senior Vice President R&D and Chief Technology Officer; NasVax, Ltd.; Ness Ziona.
authors: Ronald
authors: R
authors: Ellis
authors: Eva M
authors: EM
authors: Riedmann
mesh_terms: D035081:Editorial Policies; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D020407:Internet; D010342:Patient Acceptance of Health Care; D010506:Periodicals as Topic; D014612:Vaccines / Q000008:administration & dosage / Q000276:immunology*
chemical_list: D014612:Vaccines